Valero: 5-Star Buy in Refining
11/23/2015 7:00 am EST
Weak prices in energy are a boon for refiners: they represent a big portion of the input costs that a refiner faces, explains Seth Glickman of S&P Capital IQ in Standard & Poor's The Outlook.
Our latest Focus stock is Valero Energy (VLO), which carries S&P Capital IQ's highest investment recommendation of 5-Stars, or strong buy.
As one of the leading oil and gas refining companies in our coverage universe, with above-average projected returns, strong exposure to the US Gulf Coast, and attractive valuation, we think VLO should outperform peers.
We also anticipate a slight boost to the Brent-WTI crude oil spread over the next 12 months, which should benefit VLO as that should widen margins and encourage more export growth for refined products.
VLO is a major independent refiner, turning that crude oil into refined products such as gasoline, diesel fuel, jet fuel, heating oil, and so on.
For 2015, we see EPS of $8.65, which compares with 2014 normalized EPS of $6.68 and reflects the sizable drop in input costs.
For 2016, however, we see a modest decline to $7.17 per share. As of early November 2015, the Brent-WTI spread had dwindled to about $2.60 per barrel.
However, using recent forecasts from Bentek Energy, we think this spread could widen to the $4.50 per barrel range in 2016, which, all else being equal, should be a tailwind for refining margins.
On a variety of comparisons vs. peers, we find VLO attractive. For 2016, we estimate return on invested capital of about 10.9%, above the peer median of 10.3%.
In addition, we think VLO is currently trading at a superior free cash flow yield (7.7%) than the peer median (5.6%).
Finally, even though VLO just recently hiked its quarterly dividend by 25%, to $0.50 per share from prior $0.40 per share, we think there is potential for further such hikes in the near-term. The most recent boost to the dividend, announced in October, was the fourth such increase in the last eight quarters.
On valuation, VLO is trading at a 7.0X multiple of projected 2016 operating cash flow, below the peer median of 7.5X.
We think VLO merits a slight premium rather than a slight discount to peers. Our 12-month target price is $82, which suggests about a 17% projected gain (including the 2.8% yield).
More from MoneyShow.com:
Related Articles on STOCKS
We hold three biotech stocks in our growth portfolio — Biogen (BIIB), Bioverativ (BIVV), and R...
Under the guise of clamping down on “widespread corruption,” Prince Mohammed bin Salman ...